Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota: a Randomized, Double-blind, Placebo-controlled Clinical Trial

NCT05796921 is registered in ClinicalTrials.gov with Agnese Maria Chiara Rapisarda as lead sponsor.

NCT NCT05796921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05796921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Lead sponsor
Agnese Maria Chiara Rapisarda
Phase
Not applicable
Overall status
Completed
Start date
April 10, 2023
Completion date
May 6, 2025
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis, candidosis vaginal, urinary tract infections